Medical decision-making faces a critical blind spot that could be undermining health equity across diverse populations. When diagnostic tools perform differently based on patient skin tone, the resulting treatment disparities may be more systematic than previously recognized. This analysis reveals how racial biases embedded in clinical assessment tools translate into real-world care differences, challenging assumptions about objective medical practice. The research examined clinician responses when test accuracy varies by skin tone, documenting measurable changes in treatment decisions. Key findings show that when diagnostic tools are less reliable for patients with darker skin, clinicians often fail to adjust their interpretation appropriately. This creates a cascade effect where initial measurement bias compounds into treatment disparities. The study design controlled for actual patient health status while varying skin tone representation, isolating the impact of biased diagnostic tools on clinical judgment. These findings illuminate a previously underexplored mechanism driving health disparities beyond explicit bias or socioeconomic factors. The research suggests that even well-intentioned clinicians operating with standard protocols may inadvertently perpetuate unequal care when their diagnostic tools carry inherent racial biases. For health-conscious adults, this highlights the importance of advocating for skin tone-validated diagnostic methods and seeking second opinions when standard tests may be less accurate for your demographic. The implications extend beyond individual care to healthcare system design, suggesting that addressing measurement bias in medical devices should be a priority for achieving true health equity. This work represents a crucial step toward quantifying how technological biases translate into human health outcomes.